How to Successfully Market Allogeneic Therapies

Photo 51, a Fingerpaint company and consultancy focused solely on advanced therapeutics, shared with Pharmaceutical Executive magazine 3 approaches biopharma can use right now to market allogeneic therapies from clinical trials to market access.

In this Pharmaceutical Executive article, discover what allogeneic therapies mean to patients and the future of medicine and what needs to be done to make sure patients have access to them.